According to recent reports, Hospira, Inc. has issued a press release claiming that the public must be aware of a recall announcement linked to three lots of Carboplatin Injection, which could pose a serious risk to patients due to the fact these solutions may contain particles known as Carbpolatin crystals.
The Food and Drug Administration has indicated that Hospira customers have been notified of the recall in early November, however, another statement has been released to ensure consumers are aware of the risks associated with not following recall instructions.
Up to this moment, adverse events associated with these injections have not been reported. The potentially contaminated lots were distributed across the country and to Puerto Rico between March and September of 2012.
An investigation to determine the causes behind this issue is being held by the company.
For more details regarding this recall, click here.